Preferred Label : BNT162 Vaccine;

MeSH definition : mRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech.;

MeSH synonym : Vaccine, BNT162; COVID-19 Vaccine Pfizer-BioNTech; COVID 19 Vaccine Pfizer BioNTech; Pfizer-BioNTech, COVID-19 Vaccine; Vaccine Pfizer-BioNTech, COVID-19;

MeSH hyponym : BNT-162C2; BNT 162C2; BNT162C2; BNT-162B1; BNT 162B1; BNT162B1; BNT 162A1; BNT162A1; Pfizer Covid-19 Vaccine; Covid-19 Vaccine, Pfizer; Pfizer Covid 19 Vaccine; Vaccine, Pfizer Covid-19; Comirnaty; BNT162B2; BNT-162B2; BNT 162B2;

MeSH Related Number : 5085ZFP6SJ; 6FH8H9CL41; JV8KBX6XZG; N38TVC63NU;

Details


Main resources

You can consult :

mRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech.

PUBLIÉ LE 18/02/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-28-01-2022-au-10-02-2022
2022
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-21-10-2022-au-24-11-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-30-09-2022-au-20-10-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
menorrhagia
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-2-09-2022-au-29-09-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-22-07-2022-au-08-09-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
PUBLIÉ LE 01/08/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-17-06-2022-au-21-07-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
pericarditis
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
PUBLIÉ LE 31/05/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-06-05-2022-au-23-05-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
PUBLIÉ LE 15/04/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-25-03-2022-au-07-04-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
vasculitis
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
PUBLIÉ LE 01/04/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-11-03-2022-au-24-03-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
PUBLIÉ LE 18/03/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-25-02-2022-au-10-03-2022
2022
false
false
false
France
French
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
brachial plexus neuritis
anemia, hemolytic, autoimmune
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://apps.who.int/iris/bitstream/handle/10665/351395/WHO-2019-nCoV-vaccinesSAGE-recommendation-BNT162b2-2022.1-fre.pdf
2022
false
false
false
Switzerland
Tozinameran
BNT162 Vaccine
orientation
vaccine, nos
vaccination
vaccines
COVID-19 Vaccines
vaccination
preventive immunization/medication
world health organization
COVID-19
emergencies
Vaccins
vaccinia
orientation, nos
Vaccinia
Off-Label use

---
PUBLIÉ LE 27/12/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-25-11-2022-au-22-12-2022
2022
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
PUBLIÉ LE 04/03/2022
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-11-02-2022-au-24-02-2022
2022
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://apps.who.int/iris/bitstream/handle/10665/350977/WHO-2019-nCoV-vaccines-SAGE-recommendation-BNT162b2-2021.3-fre.pdf
2021
false
false
false
Switzerland
COVID-19
COVID-19 Vaccines
Tozinameran
BNT162 Vaccine
practice guideline
orientation
vaccine, nos
vaccination
Vaccins
vaccinia
vaccination
world health organization
emergencies
preventive immunization/medication
Vaccinia
orientation, nos
vaccines
Off-Label use

---
https://presse.inserm.fr/bonne-tolerance-du-vaccin-bnt162b2-pfizer-biontech-et-bonne-efficacite-de-la-reponse-immunitaire-contre-les-variants-du-sars-cov-2-chez-les-patients-atteints-de-lupus-systemique/43966
2021
false
false
false
France
French
COVID-19
journal article
vaccine potency
COVID-19 Vaccines
lupus erythematosus, systemic
mRNA Vaccines
BNT162 Vaccine

---
https://sante.gouv.fr//IMG/pdf/cosv-_note_du_30_septembre_relative_a_l_efficacite_comparee_pfizer-moderna.pdf
2021
false
false
false
France
COVID-19
COVID-19 Vaccines
covid-19, RNA-based vaccine
mRNA Vaccines
Tozinameran
BNT162 Vaccine
public health guidelines
Vaccins
counseling
orientation
preventive immunization/medication
vaccine potency
vocational guidance counselor
vaccine, nos
vaccination, nos
vaccination
vaccinia, nos
Vaccinia

---
https://apps.who.int/iris/bitstream/handle/10665/342278/WHO-2019-nCoV-vaccines-SAGE-recommendation-BNT162b2-2021.2-fre.pdf
2021
false
false
false
Switzerland
COVID-19
COVID-19 Vaccines
Tozinameran
BNT162 Vaccine
public health guidelines
preventive immunization/medication
orientation
vaccine, nos
emergencies
COVID-19
vaccines
orientation, nos
vaccination
Off-Label use
vaccinia
world health organization

---
https://sante.gouv.fr//IMG/pdf/avis_du_cosv_22_avril_2021_-_interchangeabilite_des_vaccins_arnm.pdf
2021
France
coronavirus infections
pneumonia, viral
mRNA Vaccines
BNT162 Vaccine
public health guidelines
orientation
Vaccins
vaccine, nos
preventive immunization/medication
immunization schedule
vaccination, nos
counseling
messenger rna
Fracture-dislocation
rna, messenger
vocational guidance counselor
vaccinia, nos
Acanthosis nigricans
Vaccinia
vaccination
aptitude
vaccines
pandemics
viral vaccines
COVID-19
COVID-19 Vaccines

---
https://rheum.ca/wp-content/uploads/2021/05/G_FINAL-V2-FR-CRA-Recommendation-on-Covid-19-Vaccination_For-Publication.pdf
2021
false
false
false
Canada
pneumonia, viral
coronavirus infections
BNT162 Vaccine
guidelines
Cardio-Renal syndrome
autoimmune disease, nos
Vaccins
Diseases
persons
autoimmune diseases
rheumatic diseases
Vaccinia
preventive immunization/medication
health planning guidelines
vaccination
vaccination, nos
vaccination
pandemics
viral vaccines
COVID-19
COVID-19 Vaccines

---
https://www.usherbrooke.ca/baladocritique/archives/episode-39-etudes-sur-les-vaccins-bnt162b2-et-mrna-1273-contre-la-covid-19/
2021
Canada
pneumonia, viral
coronavirus infections
Tozinameran
BNT162 Vaccine
sound
vaccine, nos
vaccinia, nos
preventive immunization/medication
Vaccinia
Vaccins
Leber amaurosis
vaccines
vaccination
vaccination, nos
pandemics
viral vaccines
COVID-19
COVID-19 Vaccines

---
https://apps.who.int/iris/bitstream/handle/10665/338848/WHO-2019-nCoV-vaccines-SAGE_recommendation-BNT162b2-2021.1-fre.pdf
2021
false
false
false
Switzerland
mRNA Vaccines
Tozinameran
BNT162 Vaccine
public health guidelines
Vaccins
Vaccinia
emergencies
vaccination
Off-Label use
vaccination
preventive immunization/medication
vaccine, nos
vaccines
vaccinia
world health organization
vaccination
vaccinia
viral vaccines
coronavirus infections
pneumonia, viral
pandemics
COVID-19
COVID-19 Vaccines

---
https://www.cbip.be/fr/articles/3518?folia=3503
2021
false
false
false
Belgium
French
journal article
ChAdOx1 nCoV-19 Vaccine
vaccination
Tozinameran
vaccine potency
mRNA Vaccines
Tozinameran
BNT162 Vaccine
pneumonia, viral
coronavirus infections
pandemics
viral vaccines
coronavirus infections
viral vaccines
coronavirus infections
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
vaccines, synthetic
mRNA Vaccine

---
https://www.has-sante.fr/jcms/p_3227132/fr/strategie-de-vaccination-contre-le-sars-cov-2-place-du-vaccin-a-arnm-comirnaty-bnt162b2
2020
false
false
false
France
coronavirus infections
pneumonia, viral
mRNA vaccine
covid-19, RNA-based vaccine
adult
mass vaccination
immunization programs
immunization programs
aged
risk factors
mRNA Vaccines
Tozinameran
BNT162 Vaccine
public health guidelines
health planning guidelines
vaccination
vaccination
rna, messenger
pandemics
viral vaccines
pandemics
COVID-19
COVID-19 Vaccines
vaccines, synthetic
mRNA Vaccine

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.